A Pilot Study of Proinflammatory Cytokines and Fatigue in Women With Breast Cancer During Chemotherapy

Cancer Nursing

Volumn 40, Issue 4, 2017, Pages 323-331

  Raudonis, Barbara M ^a   Kelley, Ingrid H ^b   Rowe, Nancy ^a   Ellis, Jenny ^c  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c Texas Health Harris Methodist Hospital   (United States)

Author keywords

Adjuvant chemotherapy; Breast cancer; Cancer related fatigue; Interleukin 6; Proinflammatory cytokines; Tumor necrosis factor

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; BLOOD SAMPLING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL PRACTICE; CONFERENCE PAPER; CONTROLLED STUDY; CONVENIENCE SAMPLE; FEMALE; GENETIC VARIABILITY; HUMAN; LONGITUDINAL STUDY; MULTIPLE CYCLE TREATMENT; PILOT STUDY; PRIORITY JOURNAL; BLOOD; BREAST NEOPLASMS; CHEMICALLY INDUCED; FATIGUE; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FATIGUE; FEMALE; HUMANS; INTERLEUKIN-6; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84976394857     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0000000000000406     Document Type: Conference Paper

References (40)

1. American Cancer Society 2015. Breast cancer facts and figures 2013-2014. http://www.cancer.org/research/cancerfactsstatistics/breast-cancer-factsfigures. Accessed March 31, 2015.
2. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB. Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. J Clin Oncol. 2005;23(27): 6613-6622.
3. de Jong N, Courtens AM, Abbu-Saad HH, Schouten HC. Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs. 2002;25(4):283-299.
4. Pusztai L, Mendoza TR, Reuben JM, et al. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004;25:94-102.
5. Berger AM, Grem JL, Visovsky C, Marunda HA, Yurkovick JM. Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer. Oncol Nurs Forum
6. Jager A, Sleijfer S, van der Rijt CCD. The pathogenesis of cancer-related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer. 2008;44:175-181.
7. Gilbertson-White S, Aouizerat BE, Miaskowski C. Methodologic issues in the measurement of cytokines to elucidate the biological basis for cancer symptoms. Biol Res Nurs. 2011;13(1):15-24.
8. Payne JK. A neuroendocrine-based regulatory fatigue model. Biol Res Nurs. 2004;6:141-150.
9. Miaskowski C, Aouizerat BE. Biomarkers: symptoms, survivorship, and quality of life. Semin Oncol Nurs. 2012;28(2):129-138.
10. Collado-Hidalgo A, Bower JE, Ganz PA, Irwin MR, Cole SW. Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings. Brain Behav Immun. 2008;22:1197-1200.
11. Aouizerat BE, Dodd M, Lee K, et al. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs. 2009;11(1):27-41.
12. Bower JE, Ganz PA, Irwin MR, Castellon S, Arevalo J, Cole SW. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol. 2011;29(26):3517-3522.
13. Wood LJ, Nail LM, Gilster A, Winters KA, Elsea CR. Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum. 2006;33(3):535-542.
14. Thomson AW, Lotze MT. The Cytokine Handbook. London: Academic Press; 2003.
15. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? Cancer. 2003; 97:2919-2925.
16. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncologyi: Cancer-Related fatigue. 2015; v2.2015:MS-3. http://www.nccn.org/professionals/physician-gls/pdf/fatigue.pdf. Accessed June 20, 2015.
17. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009; 9:361-371.
18. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216.
19. Moresco EMY, LaVine D, Beutler B. Toll-like receptors. Curr Biol. 2011; 21(13):R488-R493.
20. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491-503.
21. Smith JP, D'Aiuto FD, Palmen J, et al. Association of serum interleukin-6 concentration with a functional IL6-6331T9C polymorphism. Clin Chem. 2008;54(5):841-850.
22. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer. 2001;92(6):1684.
23. Jain S, Mills PJ. Cytokines, chronic stress, and fatigue. In: Fink G, ed. Encyclopedia of Stress. 2nd ed. Amsterdam, the Netherlands: Academic Press; 2007:698-704.
24. Von Ah DM, Kang DH, Carpenter JS. Predictors of cancer-related fatigue in women with breast cancer before, during, and after adjuvant therapy. Cancer Nurs. 2008;31(2):134-144.
25. Jacobsen PB, Donovan KA, Small BJ, Jim HS, Munster PN, Andrykowski MA. Fatigue after treatment for early stage breast cancer: a controlled comparison. Cancer. 2007;110(8):1851-1859.
26. Isaac S, Michael WB. Handbook in Research and Evaluation. 3rd ed. San Diego, CA: EDITS Publishers; 1995.
27. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The Revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998;25(4):677-684.
28. Berger AM, Lockhart K, Agrawal S. Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens. Oncol Nurs Forum. 2009;36(5):563-570.
29. Balkwill F. Cytokine Cell Biology. London: Oxford University Press; 2000.
30. McCulloch CE, Searle SR. Generalized, Linear, & Mixed Models. New York, NY: John Wiley & Sons; 2001.
31. Brown CG, McGuire DB, Beck SL, Peterson DE, Mooney KH. Visual graphical analysis: a technique to investigate symptom trajectories over time. Nurs Res. 2007;56(3):195-201.
32. Erickson JM, Beck SL, Christian B, et al. Patterns of fatigue in adolescents receiving chemotherapy. Oncol Nurs Forum. 2010;37(4):444-455.
33. de Jong N, Kester ADM, Schouten HD, Abu-Saad HH, Courtens AM. Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients. Cancer Nurs. 2006;29(6):467-477.
34. Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M. I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res. 2010;19:1419-1427.
35. Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. The Oncologist. 2007; 12(suppl 1):4-10.
36. Miller M, Maguire R, Kearney N. Patterns of fatigue during a course of chemotherapy: results from a multi-centre study. Eur J Oncol Nurs. 2007; 11:126-132.
37. Prigozin A, Uziely B, Musgrave CF. The relationship between symptom severity and symptom interference, education, age, marital status, and type of chemotherapy treatment in Israeli women with early-stage breast cancer. Oncol Nurs Forum. 2010;37(6):E411-E418.
38. Bower JE, Ganz PA, Irwin MR, Castellon S, Arevalo J, Cole SW. Cytokine genetic variations and fatigue among patients with breast cancer. J Clin Oncol. 2013;31:1656-1661.
39. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR. Neuroendocrine-immune mechanismof behavioral comorbidities in patients with cancer. J Clin Oncol. 2008;26(6):971-982.
40. Miaskowski C, Dodd M, Lee K, et al. Preliminary evidence of an association between a functional IL6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. J Pain Symptom Manage. 2010;40(4):531-544.